3rd European Healthy Living with HIV – Presentations

 

FRIDAY, 7 SEPTEMBER 2018

 Session 1  -  Value-based Healthcare and mental health
 VBHC/quality of live in HIV: lessons learned from implementation
Guido van den Berk, MD
Onze Lieve Vrouwe Gasthuis, The Netherlands
 Mental health in HIV care
Jordi Blanch, MD, PhD
Hospital Clínic of Barcelona, Spain
 

Factors of Risk and Resilience in the Neurodevelopment of Children Affected by HIV 
Michael Boivin, PhD, MPH 
Michigan State University, USA

  Abstract-driven presentations
 Health-related quality of life in HIV infected people who inject drugs in Ukraine
Anna Piddubna
 Living a valuable and meaningful life with HIV beyond viral suppression:
The quality of life of people living with HIV in Sweden

Galit Zeluf
 Met and unmet needs of people living with HIV in the UK:
results of the Positive Voices 2017 survey

Meaghan Kall
 Health-related quality of life of adults living with HIV in England and Wales:
a utility analysis of EQ-5D-5L compared to the general population

Meaghan Kall
 Session 2  -  Break-out sessions
 No presentations available for these sessions
  

SATURDAY, 8 SEPTEMBER 2018

 Session 3  -  Non-HIV related comorbidities
 Renal health in people living with HIV
Bruce Hendry, BM, BCh, MD, PhD
King’s College London, United Kingdom
 Oncology - Treating cancer in HIV infected patients 
Mark Bower, PhD, FRCP, FRCPath
Chelsea & Westminster Hospital, United Kingdom
 Abstract-driven presentation
 Demographics of HIV+ patients with non HIV-related comorbidities 
Sarah Brown
 Fat indexes that predict bone composition in HIV infected persons. 
Nuria Perez
 Analysis of the Body Composition in a Cohort of HIV infected people.
The Vitruvi Study 

Carla Estany Quera
 Comorbidities and polypharmacy in people with HIV in the UK:
results of the Positive Voices 2017 survey 

Meaghan Kall
  
 Session 4  -  Optimizing clinical management and patient care
 Does choice of antiretroviral drugs matter for inflammation?
Cristina Mussini, MD
University Hospital Modena, Italy
 Integrating future therapies into routine care
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
 Optimizing care for women living with HIV
Laura Waters, MD
Mortimer Market Centre, United Kingdom
 Designing e-health interventions for HIV care
Joop Arends, MD
UMC Utrecht, The Netherlands
 Abstract-driven presentations
 Trends in 2 drug regimen (2DR) use in the eu5 
Katie Bradshaw
 What do health systems need to monitor in order to support healthy living with  HIV? An assessment of how comprehensively global and European monitoring  frameworks address non-AIDS-defining comorbidities 
Kelly Safreed-Harmon
(Not available)
 Results of anxienty and depression screening as part of routine HIV care 
Marie Jose Kleene